Literature DB >> 21070603

Impact of MELD on waitlist outcome of retransplant candidates.

H J Kim1, J J Larson, Y S Lim, W R Kim, R A Pedersen, T M Therneau, C B Rosen.   

Abstract

Under the current allocation system for liver transplantation (LTx), primary and retransplantation (ReTx) are treated identically. The aims of this study were (1) to compare the risk of death between ReTx and primary LTx candidates at a given MELD score and (2) to gauge the impact of the MELD-based allocation system on the waitlist outcome of ReTx candidates. Based on data of all waitlist registrants in the United States between 2000 and 2006, unique adult patients with chronic liver disease were identified and followed forward to determine mortality within six months of registration. There were a total of 45,943 patients waitlisted for primary LTx and 2081 registered for ReTx. In the MELD era (n = 30,175), MELD was significantly higher among ReTx candidates than primary LTx candidates (median, 21 vs. 15). Within a range of MELD scores where most transplantation took place, mortality was comparable between ReTx and primary candidates after adjusting for MELD. The probability for LTx increased significantly following implementation of the MELD-based allocation in both types of candidates. We conclude that by and large, primary and ReTx candidates fare equitably under the current MELD-based allocation system, which has contributed to a significant increase in the probability of LTx. ©2010 The Authors Journal compilation©2010 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2010        PMID: 21070603      PMCID: PMC4547838          DOI: 10.1111/j.1600-6143.2010.03315.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

1.  MELD and PELD: application of survival models to liver allocation.

Authors:  R H Wiesner; S V McDiarmid; P S Kamath; E B Edwards; M Malinchoc; W K Kremers; R A Krom; W R Kim
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

2.  Does MELD work for relisted candidates?

Authors:  Erick Edwards; Ann Harper
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

3.  The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution.

Authors:  Robert S Brown; John R Lake
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

4.  Mortality while awaiting liver retransplantation: predictability of MELD scores.

Authors:  K D S Watt; T Menke; E Lyden; T M McCashland
Journal:  Transplant Proc       Date:  2005-06       Impact factor: 1.066

5.  Repeat organ transplantation in the United States, 1996-2005.

Authors:  J C Magee; M L Barr; G P Basadonna; M R Johnson; S Mahadevan; M A McBride; D E Schaubel; A B Leichtman
Journal:  Am J Transplant       Date:  2007       Impact factor: 8.086

6.  Late orthotopic liver retransplantation: indications and survival.

Authors:  F G Durán; R A Cercadillo; L Santos; A de Diego; J Ferreiroa; E Valdecantos; G Clemente
Journal:  Transplant Proc       Date:  1998-08       Impact factor: 1.066

7.  Long-term survival after retransplantation of the liver.

Authors:  J F Markmann; J S Markowitz; H Yersiz; M Morrisey; D G Farmer; D A Farmer; J Goss; R Ghobrial; S V McDiarmid; R Stribling; P Martin; L I Goldstein; P Seu; C Shackleton; R W Busuttil
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

8.  Validation and refinement of survival models for liver retransplantation.

Authors:  Hugo R Rosen; Martin Prieto; Teresa Casanovas-Taltavull; Valentin Cuervas-Mons; Olaf Guckelberger; Paolo Muiesan; Russell W Strong; Wolf O Bechstein; John O'grady; Atif Zaman; Benjamin Chan; Joaquin Berenguer; Roger Williams; Nigel Heaton; Peter Neuhaus
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

9.  Results of the first year of the new liver allocation plan.

Authors:  Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

10.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

View more
  11 in total

1.  Futility and rationing in liver retransplantation: when and how can we say no?

Authors:  Scott W Biggins
Journal:  J Hepatol       Date:  2012-02-04       Impact factor: 25.083

Review 2.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

Review 3.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

Review 4.  Model for end-stage liver disease score and MELD exceptions: 15 years later.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

5.  Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.

Authors:  S W Biggins; J Gralla; J L Dodge; K M Bambha; S Tong; A E Barón; J Inadomi; N Terrault; H R Rosen
Journal:  Am J Transplant       Date:  2014-09-19       Impact factor: 8.086

6.  Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis.

Authors:  Helge Bruns; Vladimir J Lozanovski; Daniel Schultze; Norbert Hillebrand; Ulf Hinz; Markus W Büchler; Peter Schemmer
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Retransplantation in Late Hepatic Artery Thrombosis: Graft Access and Transplant Outcome.

Authors:  Bettina M Buchholz; Shakeeb Khan; Miruna D David; Bridget K Gunson; John R Isaac; Keith J Roberts; Paolo Muiesan; Darius F Mirza; Dhiraj Tripathi; M Thamara P R Perera
Journal:  Transplant Direct       Date:  2017-07-05

8.  Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation.

Authors:  Mohammad A B Al-Freah; Carl Moran; Matthew R Foxton; Kosh Agarwal; Julia A Wendon; Nigel D Heaton; Michael A Heneghan
Journal:  World J Hepatol       Date:  2017-07-18

9.  Effects of infection on post-transplant outcomes: living versus deceased donor liver transplants.

Authors:  Osama Siddique; Ayesha S Siddique; Jason T Machan; Kittichai Promrat
Journal:  Clin Exp Hepatol       Date:  2018-01-31

10.  Experience Since MELD Implementation: How Does the New System Deliver?

Authors:  Markus Quante; Christoph Benckert; Armin Thelen; Sven Jonas
Journal:  Int J Hepatol       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.